Korea Pharma-Bio Forum 2026 Beneficiary Stocks: Hanmi Pharmaceutical (128940.KS), ST Pharm (237690.KQ), Inventage Lab (389470.KQ) and CuroCell (372320.KQ)
Korean biotech stocks after the MBF2026 forum: Hanmi’s pipeline value fell 75%, ST Pharm’s backlog is 1.4x sales, CuroCell prices in 288 CAR-T patients.